Gaush Meditech Balance Sheet Health
Financial Health criteria checks 5/6
Gaush Meditech has a total shareholder equity of CN¥1.6B and total debt of CN¥568.2M, which brings its debt-to-equity ratio to 36.5%. Its total assets and total liabilities are CN¥2.8B and CN¥1.3B respectively. Gaush Meditech's EBIT is CN¥171.4M making its interest coverage ratio 4.1. It has cash and short-term investments of CN¥754.2M.
Key information
36.5%
Debt to equity ratio
CN¥568.16m
Debt
Interest coverage ratio | 4.1x |
Cash | CN¥754.20m |
Equity | CN¥1.56b |
Total liabilities | CN¥1.25b |
Total assets | CN¥2.81b |
Recent financial health updates
We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Oct 27We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Jun 03Recent updates
We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Oct 27The Consensus EPS Estimates For Gaush Meditech Ltd (HKG:2407) Just Fell A Lot
Jul 19Here's What's Concerning About Gaush Meditech's (HKG:2407) Returns On Capital
Jul 16Gaush Meditech Ltd (HKG:2407) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough
Jun 19We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt
Jun 03Revenues Working Against Gaush Meditech Ltd's (HKG:2407) Share Price Following 25% Dive
Apr 05Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)
Dec 07A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)
Aug 08Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry
Jun 01Financial Position Analysis
Short Term Liabilities: 2407's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥740.1M).
Long Term Liabilities: 2407's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥511.8M).
Debt to Equity History and Analysis
Debt Level: 2407 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2407's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 2407's debt is well covered by operating cash flow (22.4%).
Interest Coverage: 2407's interest payments on its debt are well covered by EBIT (4.1x coverage).